BCL-2 encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants, produced by alternate splicing, differ in their C-terminal ends.Muller IM, et al. (2005) Mol Pharmacol.Jin Z, Gao F,et al. J Biol Chem 2004 Sep 17; 279(38): 40209-19.Kumar Biswas S,et al. Mol Cancer Ther 2004 Mar; 3(3): 327-34.Huang ST,et al. (2002)FASEB J; 16(8): 825-32.Yamamoto K,et al. (1999) Mol Cell Biol; 19(12): 8469-78.
Host
Rabbit
Immunogen
Peptide sequence around aa.68~72 (R-T-S-P-L) derived from Human BCL-2.
Involvement In Disease
A chromosomal aberration involving BCL2 has been found in chronic lymphatic leukemia. Translocation t(14;18)(q32;q21) with immunoglobulin gene regions. BCL2 mutations found in non-Hodgkin lymphomas carrying the chromosomal translocation could be attributed to the Ig somatic hypermutation mechanism resulting in nucleotide transitions.
Raised In
Rabbit
Reactivity
Human
Regulatory
RUO
Relevance
BCL-2 encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants, produced by alternate splicing, differ in their C-terminal ends.
Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release
Pathway
Estrogen signaling pathway Hedgehog signaling pathway HIF-1 signaling pathway Jak-STAT signaling pathway PI3K-Akt signaling pathway Focal adhesion NF-kappa B signaling pathway Apoptosis Autophagy Necroptosis Protein processing in endoplasmic reticulum NOD-like receptor signaling pathway AGE-RAGE signaling pathway in diabetic complications ER Stress pathway Neurotrophin signaling pathway
Protein Families
Bcl-2 family
Tissue Specificity
Expressed in a variety of tissues.
Weight
22,337 Da
Buffer
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Form
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Format
liquid
Purification
Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide.
Purity
Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide.
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.